SunMed
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
SunMed - overview
Established
2023
Location
Huzhou, Zhejiang, China
Primary Industry
Medical Devices & Equipment
About
Based in Huzhou, China and founded in 2023, Zhejiang SunMed Healthcare Technology Co. , Ltd. , dba SunMed, develops self-administered drug-delivery devices and related digital-monitoring systems for the medical-device and pharmaceutical sectors. The firm provides mechanical and electronic drug-delivery devices, NFC glucose-monitoring tools, and medication-tracking management systems, with multiple products already contracted with domestic and international pharma companies and preparing for global market launches.
The company has built a multi-product platform supported by more than fifty active patents and has advanced several devices toward commercialization in partnership with global drugmakers. The company works with pharmaceutical manufacturers and healthcare providers to supply mechanical and electronic drug-delivery devices, NFC-enabled glucose-detection tools, and digital medication-tracking systems. Its portfolio is designed to improve patient adherence, support chronic-disease management, and enable seamless integration of delivery devices with pharmaceutical therapies. The company generates revenue through device sales, co-development partnerships with pharmaceutical companies, and licensing of its drug-delivery technology platforms.
In December 2025, SunMed closed Series A+ funding.
Primary Industry
Medical Devices & Equipment
Sub Industries
Healthcare, Medical Devices & Equipment
Company Stage
Series A
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.